Skip to content
Norton & Elaine Sarnoff Center for Jewish Genetics Logo
  • Home
  • Get Screened
    • Carrier Screening
    • Hereditary Cancer Testing
  • About Us
    • Board Members
    • Staff
  • Genetic Disorders
    • Types of Genetic Disorders
    • Jewish Genetic Disorder FAQs
    • Rabbinical Insights
  • Hereditary Cancer
    • Types of Hereditary Cancer Genes
    • BRCA Mutations
    • Lynch Syndrome
    • Assess Your Risk
    • Cancer FAQs
    • Cancer Resources
  • Resources
    • Preimplantation Genetic Testing
    • Family Health History
    • Teach Jewish Genetics
    • Community Resources
    • Educational Brochures
    • For Medical Professionals
    • Personal Stories
    • Blog
  • Get Involved
    • Events
    • Donate
Previous Next

APC – Familial Adenomatous Polyopsis


Pathogenic variants (disease-causing) in the APC gene cause familial adenomatous polyposis (FAP) and attenuated FAP, conditions marked by tens to thousands of colorectal polyps (polyposis) and a high lifetime risk of colorectal cancer if not managed. APC variants can also increase risks for duodenal (small bowel)/upper gastrointestinal polyps and cancer, desmoid tumors (benign but problematic tumors), and, less commonly, thyroid cancer and hepatoblastoma (primarily in young children). Management involves increases screening for polyps and tumors starting a younger age with routine surveillance.

In addition, there is a specific variant in the APC gene called I1307K that is seen more commonly in the Askenazi Jewish population, with about 6–10% carrying this variant. The APC I1307K variant increases colorectal cancer risk by 2-3 fold but typically does not cause polyposis or other FAP-related tumors.

Pathogenic variants in APC exhibit autosomal dominant inheritance. This means there is a 50% chance the condition can be passed from generation-to-generation. First degree relatives (parents, siblings, children) have a 50% chance to have the same pathogenic variant whereas second degree relatives (grandparents, aunts/uncles, nieces/nephews, half-siblings) have a 25% chance. More distant relatives have lower chances of having the same pathogenic variant when one is identified in the family.

Resources:

FORCE

National Cancer Institute

Written December 2025

Scott Weissman2025-12-11T20:18:04+00:00December 11, 2025|

Share This Story, Choose Your Platform!

FacebookXRedditLinkedInWhatsAppTumblrPinterestVkXingEmail

The Norton & Elaine Sarnoff Center for Jewish Genetics is a supporting foundation of the Jewish United Fund, and is supported in part by the Michael Reese Health Trust.

30 S Wells
Chicago, IL 60606
312-357-4718
[email protected]

About
  • About Us
  • Genetic Disorders
  • Hereditary Cancer
  • Donate
Resources
  • Medical Professionals
  • Teach Jewish Genetics
  • Events

©2025 Norton & Elaine Sarnoff Center for Jewish Genetics

Page load link
Go to Top